Hulamin (HLM) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
25 May, 2026Opening remarks and agenda
The AGM was conducted in a hybrid format, with both in-person and electronic participation, and all board members, key executives, auditors, and scrutineers were present.
Notice of the meeting, integrated report, financial statements, and sustainability report were distributed in advance, with updates on directorship and venue provided.
Shareholders were encouraged to submit questions and votes both in advance and during the meeting, with a structured process for addressing queries.
The meeting was confirmed as quorate, and voting was conducted by poll as per the company's MOI.
Financial performance review
Audited annual financial statements for the year ended 31 December 2025 were presented, including reports from the Audit Committee, directors, and external auditors.
Shareholders raised concerns about declining share price, historical losses, and lack of dividends since 2019.
Management acknowledged past underperformance and outlined efforts to restore profitability and maximize production.
Funding capacity and headroom were discussed, with management expressing confidence in current liquidity and plans to optimize working capital.
Board and executive committee updates
Ordinary resolutions were tabled for the re-election of directors and election of committee members, with profiles included in the governance report.
Recent changes in executive leadership and ongoing efforts to bring in external technical expertise were highlighted.
Latest events from Hulamin
- Revenue up 8% but normalized EBITDA down 20% amid restructuring and cost pressures.HLM
H1 202530 Mar 2026 - All resolutions passed, with strategic reviews and dividend concerns addressed by management.HLM
AGM 202528 Mar 2026 - Revenue up 2% but EBIT down 77% amid operational setbacks; recovery expected in 2026.HLM
H2 202528 Mar 2026 - Turnover and EBITDA declined, but local sales and capital investment surged.HLM
H1 202428 Mar 2026 - Normalized EBIT fell 22% year-over-year as strategic CapEx and net debt increased.HLM
H2 202428 Mar 2026